Member Info for Esspekay

Feels like we have a week with a break out. The next week draws back. A rinse and repeat.

I find it more sustainable this way. We're all impatient as the fundamentals have only got better.

So juvenile

(Beat me to it)

Tend to agree on the direction on where the SP is heading. Doesn't feel like much is happening behind the scenes and hope to be wrong. There is nothing to suggest that unless a material RNS is released in the next few days (not a business or general update) then that will continue.

It's a hold in hope feel rather than a hold in judgement. Which, doesn't feel like the best investment case atm.

We're overdue a material update.

Hopefully not for another 12 months.

This is a company that can go it alone. Retain control and maximise shareholder value in a very short period of time. Doesn't need a takeover to achieve that.

i know this makes me sounds like a bit of a ****but it's tyseley (ties-lee) 😂

260p - 300p and I would consider selling up.

700p is my long term end goal.

Https://www.londonstockexchange.com/news-article/MKA/mka-cptk-announce-business-combination-agreement/17116827

Boom

Theirs for £750m haha

If it needed 3 days it would be a longer timeframe. I think it's pretty much ready but 3 days gives an extra bit of wiggle room just in case. It'll get done today.

Zeus hopefully have something big tee'd up and ready to go. They won't do these things for free!

£2, no less.

There is absolutely no factual basis for this, but I have a feeling we may see an intraday RNS today.

Anyone else?

Ah, just normal expectations then 😂

What are people expecting out of interest?

Great news.

Almost twice the current market cap haha

Anyone give me a quick idiots explanation why this happens? Thanks haha

A few % a day and by 2027 we would catch up to where it should be haha

Bizarre share price.

Only thing I can think of is the awareness of the company. But it'll come and the share price will follow.

Plenty of people will be searching rate earth's. Not sure we're top of the list.... Yet.

So not good enough?

STS is a huge market, SGC is niche with no current effective treatment regime.

'Holy bail' (out)?

I'll bite. Even though I know that you're being an obtuse n0bhead.

STS hasn't been ditched. It's been moved down the pecking order.

SGC is the frontrunner because it'll get to the clinic quicker.

STS is there with TNBC. But they will take longer to get to clinic as the trials have longer median PFS the fore require more funding.

If you've got a product that will be revenue generating, and you can get it to market earlier than your other, equally expensive products, you'd get the revenue in first. Right?

Or would you go with the longest, resource draining option first?

Maybe you would. You seem to have that intelligence.

It was answered today. It's taken a backseat as the median PFS is 8+ months and it'll take too long and too costly to keep going with it. When they switched to SGC which has no standard of care and can be in the clinic sooner which gives a proof of concept.